» Articles » PMID: 34400427

Isolated Juxtapapillary Retinal Capillary Haemangioblastoma and Exudative Maculopathy in an Elderly Patient Without Von Hippel-Lindau Syndrome: Combined Proton Beam Radiotherapy and Intravitreal Anti-VEGF

Overview
Journal BMJ Case Rep
Specialty General Medicine
Date 2021 Aug 17
PMID 34400427
Authors
Affiliations
Soon will be listed here.
Abstract

A 71-year-old Caucasian man presented with an isolated juxtapapillary retinal capillary haemangioblastoma on the superior and temporal left optic disc with active exudation resulting in macular intraretinal and subretinal fluid, reduced vision, scotoma and distortion with progression over 6 weeks. He did not have von Hippel-Lindau syndrome. After proton beam radiotherapy (PBR), the tumour size remained unchanged, but did not stop the exudation. Three anti-vascular endothelial growth factor (VEGF) (ie, bevacizumab) injections at monthly intervals resulted in reduced macular oedema. Combined therapy with PBR and anti-VEGF injections sustained our patient's vision at 12 months follow-up.

Citing Articles

Vision-Threatening Complications of Juxtapapillary Retinal Capillary Hemangioma: A Case of Retinal Artery Occlusion.

Han J, Wang S, Hu Y Am J Case Rep. 2025; 26:e946514.

PMID: 39972971 PMC: 11851348. DOI: 10.12659/AJCR.946514.

References
1.
McGrath L, Mudhar H, Salvi S . Hemangioblastoma of the optic nerve. Surv Ophthalmol. 2018; 64(2):175-184. DOI: 10.1016/j.survophthal.2018.10.002. View

2.
Hussain R, Jmor F, Damato B, Heimann H . Verteporfin photodynamic therapy for the treatment of sporadic retinal capillary haemangioblastoma. Photodiagnosis Photodyn Ther. 2015; 12(4):555-60. DOI: 10.1016/j.pdpdt.2015.10.008. View

3.
McCabe C, Flynn Jr H, Shields C, Shields J, Regillo C, McDonald H . Juxtapapillary capillary hemangiomas. Clinical features and visual acuity outcomes. Ophthalmology. 2000; 107(12):2240-8. DOI: 10.1016/s0161-6420(00)00422-x. View

4.
Atebara N . Retinal capillary hemangioma treated with verteporfin photodynamic therapy. Am J Ophthalmol. 2002; 134(5):788-90. DOI: 10.1016/s0002-9394(02)01648-3. View

5.
Gonzalez-Rodriguez B, Villar Gomez de Las Heras K, Aguirre D, Rodriguez-Padial L, Albinana V, Recio-Poveda L . Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial. BMJ Open Ophthalmol. 2019; 4(1):e000203. PMC: 6557078. DOI: 10.1136/bmjophth-2018-000203. View